TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

36.60$ -3.8% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IDYA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – -200.6% – – – –
– +126.6% +40.5% +10.9% +24.9% +21.8% +90.8% -4.3% +19.8%
– +598.5% +128.2% +66.5% +128.2% +41.2% +59.0% +87.9% +32.7%
– – -59.4% +145.2% +97.5% +41.2% – – –
– +5.8% -117.2% – -121.1% – – – -83.8%
– -2.8% -20.8% -63.6% +436.3% +30.2% -31.2% +62.9% -38.6%
– +607.7% – -6,556.6% -52.4% -52.1% +374.4% +217.2% –
– – – – – – – – –
– +502.9% -52.0% -97.6% +7,311.0% +0.1% – – –
– – – – – – – – –
– +502.5% -52.0% +154.4% +13.0% -33.2% +273.3% +86.8% -95.6%
– – -7.0% +180.0% -47.3% -217.0% – -181.5% –
– – – – -206.3% – – – –

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?